Blog

Victorian pharmacist Pooja Sharma named PSA Symbion Early Career Pharmacist of the Year

31 July 2026

 

The Pharmaceutical Society of Australia (PSA) has named Melbourne pharmacist, Pooja Sharma MPS, the 2026 PSA Symbion Early Career Pharmacist of the Year for her exceptional leadership and commitment to improving patient care.  

 

The PSA Symbion Early Career Pharmacist of the Year Award recognises an emerging pharmacist who has demonstrated excellence in pharmacy practice research, and or innovation, and have contributed to advancing pharmacy practice.  

 

PSA National President, Professor Mark Naunton MPS, congratulated Ms Sharma on being named the PSA Symbion Early Career Pharmacist of the Year and acknowledged the importance of recognising early career pharmacists on their successes.  

 

“Ms Sharma has been recognised for developing pharmacist-led models of care, delivering medication review services across Victoria and the Northern Territory, supporting more than 700 patients through pharmacist-led primary care services, and providing care to underserved and high-risk populations,” Professor Naunton said.  

 

“In a relatively short period of time, she has demonstrated an extraordinary commitment to the profession and patients, working across community pharmacy, aged care and medication review services. 

 

“I congratulate Pooja on her recognition and look forward to seeing her continue to drive patient care throughout her pharmacy journey.”  

 

PSA26, ICC Sydney: J&A Photography – Josh Woning

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

RMIT student crowned PSA Viatris Pharmacy Student of the Year

31 July 2026

 

The Pharmaceutical Society of Australia (PSA) is pleased to announce Alexandra Ravenhall from RMIT University as the winner of the 2026 PSA Viatris Pharmacy Student of the Year (PSOTY) competition. 

 

Presented annually, the PSA Viatris PSOTY competition recognises and celebrates outstanding pharmacy students from across Australia, challenging finalists to demonstrate their clinical knowledge, communication, and patient counselling skills in a rigorous national competition. 

 

Alexandra was selected as the winner by an esteemed judging panel comprising of PSA Board Director, Dr Amanda Cross FPS, respected rural and early career pharmacist, Shaylee Mills MPS, and Ian Currie MPS, Product Manager at Viatris. 

 

Sophia Watson from Curtin University, a fourth-year pharmacy student, was awarded the People’s Choice Award, voted for by delegates attending PSA26. 

 

The finalists were assessed on their ability to engage with patients, build rapport, gather relevant clinical information, identify appropriate referral points, and provide safe, patient-centred advice. 

 

Dr Amanda Cross FPS congratulated Alexandra on being named the PSA Viatris PSOTY and applauded all finalists for making it an exceptional competition.  

 

“The finalists demonstrated the critical skills we expect to see from modern pharmacists, from communicating effectively, to building trust with patients, demonstrating their clinical reasoning, and supporting the quality use of medicines,” Dr Cross said.  

 

“These students represent a bright future for the profession, and they should all be proud of their achievements. Congratulations to Alexandra for her highly competitive performance and all the finalists for participating.”  

 

As the national winner, Alexandra joins an impressive cohort of emerging pharmacy leaders who have excelled through the PSOTY program and gone on to make significant contributions to the profession. 

 

PSA congratulates Alexandra, Sophia, and all finalists for their outstanding performances and thanks Viatris for its ongoing support of the competition and commitment to fostering the next generation of pharmacists. 

 

PSA26, ICC Sydney: J&A Photography – Josh Woning
PSA26, ICC Sydney: J&A Photography – Josh Woning

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA recognises Australia’s leading pharmacists at 2026 Excellence Awards

31 July 2026

 

The Pharmaceutical Society of Australia (PSA) has tonight announced the recipients of the 2026 PSA Symbion Excellence Awards, celebrating outstanding pharmacy leadership, innovation, research, and patient care across the profession.  

 

The PSA Symbion Excellence Awards recognise pharmacists who have demonstrated outstanding leadership, innovation, and dedication to improving the health of the patients and communities they serve. 

 

The 2026 PSA Symbion Excellence Award winners are: 

 

Lifetime Achievement Award recipient, Carlene Smith AM MPS, was recognised for her extensive contribution to Australian pharmacy and her ongoing commitment to advancing the profession. 

 

Paul Tait FPS, Pharmacist of the Year, was recognised for his excellence in pharmacy practice research and his contribution to advancing pharmacy practice. 

 

Early Career Pharmacist of the Year, Pooja Sharma MPS, was recognised for delivering innovative pharmacist-led care models, improving access to medicines services for underserved communities, and demonstrating exceptional leadership early in her career. 

 

PSA National President, Professor Mark Naunton MPS, congratulated the awardees on their well-deserved national recognition, commending them for their dedication to the PSA and the broader pharmacy profession over a substantial period. 

 

“As the name suggests, this year’s recipients represent the very best of our profession, encompassing pharmacists across different stages of their careers and working across a range of practice settings,” Professor Naunton said.  

 

“On behalf of the PSA and the pharmacy profession, I commend Carlene, Paul, and Pooja for their excellent service and contributions.”  

 

 

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Western Australian pharmacist named 2026 PSA Locumate Locum Pharmacist of the Year

31 July 2026

 

The Pharmaceutical Society of Australia (PSA) has awarded Western Australian pharmacist, Alistair Kasimi MPS, with the 2026 PSA Locumate Locum Pharmacist of the Year, for his outstanding contribution to patient care and workforce sustainability in regional communities.

 

The PSA Locumate Locum Pharmacist of the Year recognises the impact locum pharmacists make all over Australia.

 

PSA National President, Professor Mark Naunton MPS, congratulated Mr Kasimi on receiving this award.

 

“Locum pharmacists are a vital part of Australia’s pharmacy profession, filling short- and long-term staffing needs resulting from an increased demand for pharmacists across the country,” Professor Naunton said.

 

“Mr Kasimi has continued to step up and provide uninterrupted pharmacy services throughout regional Western Australia during periods of significant shortages. His dedication to the profession ensures local pharmacies can remain open, providing communities with access to healthcare.

 

“I extend my congratulations to Alistair on this award and wish to thank him, on behalf of the profession, for his contributions to maintaining access to healthcare, particularly for regional Australians, during periods of workforce shortages.”  

 

PSA26, ICC Sydney: J&A Photography – Josh Woning

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

2026 PSA MIMS Intern Pharmacist of the Year announced

31 July 2026

 

The Pharmaceutical Society of Australia (PSA) has awarded Tayler Holdman MPS, from Merimbula New South Wales, the 2026 PSA MIMS Intern Pharmacist of the Year, for her outstanding commitment to patient care and contributions to advancing pharmacy practice during her intern year.  

 

The PSA MIMS Intern Pharmacist of the Year is awarded to an intern pharmacist who has demonstrated leadership in pharmacy, a commitment to patient care and the safe use of medicines, initiative in pharmacy service delivery, and exceptional peer and professional engagement.  

 

PSA National President, Professor Mark Naunton MPS, congratulated Ms Holdman on receiving this award and was proud to see PSA recognising intern pharmacists making a difference to the profession.  

 

“Supporting our future pharmacists during their intern year is crucial to building a strong and sustainable pharmacy workforce,” Professor Naunton said.  

 

“Ms Holdman has demonstrated considerable advocacy, particularly for vulnerable patients, exemplifying the qualities of an outstanding early career pharmacist committed to improving patient outcomes. Her dedication to improving health literacy through patient education and expanding access to healthcare services in regional New South Wales is highly commendable. 

 

“Congratulations, Tayler, on this well-deserved recognition. The PSA and I look forward to seeing the impact you will no doubt make on the profession as your pharmacy journey continues.” 

 

PSA26, ICC Sydney: J&A Photography – Josh Woning

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Health Minister announces greater flexibility for medication safety programs at PSA26

31 July 2026 

 

The Pharmaceutical Society of Australia (PSA) has today welcomed the announcement that will afford pharmacists greater flexibility in delivering Home Medicines Reviews (HMRs) and Residential Medication Management Reviews (RMMRs).

 

Addressing delegates during the Opening Plenary at PSA26: The Home of Pharmacists, the Minister for Health and Ageing, the Hon. Mark Butler MP, announced negotiations are progressing on the First Pharmacy Programs Agreement (1PPA), and that from 1 November, follow-up services for the HMR and RMMR programs will be able to be delivered via telehealth.

 

The Minister’s speech reaffirmed the Government’s commitment to working with the PSA to support Australia’s pharmacists to provide more services, to more Australians, for the benefit of the pharmacy profession, patients, and the Australian health system.

 

“Pharmacists are at the heart of communities across Australia,” Minister Butler said.

 

“For many Australians, pharmacists are the first call, the first conversation, and often the first point of care when they have concerns about their health. That trusted relationship is one of the profession’s greatest strengths and one that will only become more important as our health system continues to evolve.”

 

PSA National President, Professor Mark Naunton MPS, welcomed the announcement, declaring it an important step in modernising pharmacist-delivered care and improving patient access to medication safety programs, particularly for those in rural and remote Australia who may have limited access to healthcare.

 

“The announcement is a key step in strengthening medication safety programs for Australian patients and communities,” Professor Naunton said. 

 

“We know medicines reviews are lifesaving services provided by pharmacists. They identify medicine-related problems, support the safer use of medicines, help patients optimise their medications, and provide a deeper relationship between patients and their healthcare professionals. 

 

“We thank Minister Butler for his ongoing commitment to strengthening the role of pharmacists across Australia’s healthcare system.”

 

Brooke Shelly FPS, PSA Strategic Agreements Lead, said the announcement was an important step forward for the profession, with the ability for pharmacists to now use telehealth for follow ups aligning medicines safety programs more closely with other sectors of the health system. 

 

“This reform reflects years of hard-fought advocacy from PSA and demonstrates what can be achieved when government and the profession work together with a shared focus on better patient outcomes,” Ms Shelly said.

 

“Medicines safety is fundamental to a stronger, safer health system. While we’re pleased to have greater flexibility in how these programs are delivered, there is still more to achieve, and today’s announcement provides a strong foundation for the work to come.

 

“We will continue to work constructively with the Department to build on this momentum and work towards progressing the 1PPA so that more Australians will benefit from high-quality pharmacist care, wherever they live and in the ways that best meet their needs.” 

 

The announcement reflects the success of sustained advocacy by PSA and its members, together with constructive engagement with the Australian Government. PSA remains committed to working collaboratively with Government to progress the 1PPA.

 

PSA26, ICC Sydney: J&A Photography – Josh Woning

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA26: National President says a strong profession needs a strong professional home

31 July 2026

 

PSA26: The Home of Pharmacists, the Pharmaceutical Society of Australia’s (PSA) annual national conference has commenced with National President, Professor Mark Naunton MPS, calling on pharmacists to embrace the profession’s expanding role in healthcare, declaring that a strong and united profession is essential to delivering better outcomes for Australians.

 

Opening PSA26, Professor Naunton reflected on his own professional journey, highlighting PSA’s role as the professional home for pharmacists across every practice setting. 

 

“PSA has been a home for me throughout my career, and it continues to be a home for thousands of pharmacists across Australia,” Professor Naunton said.

 

“When we put people first, organisations flourish. When PSA puts members first, pharmacists flourish, and most importantly, so do the patients and communities they serve.”

 

Professor Naunton said pharmacy was entering a period of significant change, with expanded scope of practice, increasing demand for healthcare services, and growing complexity in medicines use creating new opportunities and responsibilities for pharmacists. 

 

“The healthcare needs of Australians are growing in complexity, and our profession continues to evolve. These changes require leadership, courage, and vision,” he said.  

 

“As we look to the future of pharmacy practice, I remain optimistic.” 

 

Professor Naunton highlighted PSA’s work supporting pharmacists through education, professional standards, medicines safety advocacy, and workforce development, including the integration of the Australasian College of Pharmacy into PSA and the ongoing delivery of education programs that support evolving pharmacist services.  

 

“With pharmacists’ scope of practice rapidly expanding across the country, PSA continues to support members by preparing high-quality education and training. It is one of our top priorities.” 

 

The PSA President also acknowledged recent progress in securing paid placements for pharmacy students and thanked the Australian Government for its support of workforce reform and professional practice initiatives.  

 

“This workforce analysis, the first undertaken for the profession in more than 30 years, will help inform where future investments must be made to support quality use of medicines and safe care for Australians, regardless of where they live.”  

 

Professor Naunton also reinforced PSA’s longstanding commitment to medicines safety, ahead of the release of PSA’s eighth Medicines Safety Report focusing on culturally and linguistically diverse communities.  

 

He said medicines safety had become Australia’s 10th National Health Priority, the result of sustained advocacy by PSA and its members. 

 

Looking ahead, Professor Naunton outlined his vision for a stronger profession united through a stronger PSA. 

 

“It is my vision that PSA continues to be the home for all pharmacists. A stronger PSA means a more educated and more supported profession,” he said. 

 

“A place where we can learn, create change, lead and give back.” 

 

“Because when pharmacists have a strong and stable home, they have the confidence to practise at their very best. And when pharmacists are at their very best, Australians receive better care, use medicines more safely, and lead healthier lives.”   

 

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

PSA welcomes Paid Prac expansion for pharmacy students

23 July 2026

 

The Pharmaceutical Society of Australia (PSA), the peak national body for Australia’s 42,000 pharmacists, has welcomed today’s announcement that pharmacy students will be included in the Federal Government’s expansion of its Prac Payment Program.

 

Pharmacy students undertaking compulsory placements as part of their degree will be eligible for financial support effective from 1 July 2027, following tireless advocacy efforts from the National Australian Pharmacy Students’ Association.

 

PSA National President, Professor Mark Naunton MPS, said the announcement recognises the significant financial pressures faced by pharmacy students and comes at a pivotal time for the pharmacy profession.

 

“Frontline healthcare placements are an integral part of university study for Australia’s student pharmacists, giving them invaluable ‘hands-on’ experience,” Professor Naunton said.

 

“However, it can also be very expensive, with students forsaking part-time jobs to meet the full-time demands of placement work while also coping with general expenses like rent and fuel. It’s a significant financial burden, and we don’t want to see pharmacy students walk away from the profession because the cost of completing their studies has become too high.

 

“The payment program will make a significant practical and financial difference to students undertaking this critical component of their tertiary education, and we look forward to seeing the impact next year as we welcome graduates into one of the nation’s most trusted healthcare professions.” 

 

Professor Naunton also acknowledged the contributions of former NAPSA President Sebastian Harper and current NAPSA National President Mia Avram to this announcement: 

 

“I extend my congratulations to Sebastian, Mia, and the broader NAPSA leadership teams for their hard work in securing the paid prac program for pharmacy students.”

 

Mia Avram, NAPSA’s recently elected National President, acknowledged the announcement, saying:

 

“This is a landmark moment for pharmacy students across Australia. Expanding Commonwealth Prac Payments recognises the essential contribution pharmacy and allied health students make during their placements and will help ensure financial barriers don’t stand in the way of training our future workforce.”

 

Immediate Past President Sebastian Harper, who led NAPSAs advocacy across two terms, also welcomed the announcement:

 

“I was proud to stand alongside thousands of pharmacy and allied health students over the last few years to advocate for this change, and today this win is theirs. It will mean pharmacy students don’t have to decide between putting food on the table and finishing their degree, and for that, NAPSA and our entire profession should be proud.” 

 

Media contact: Leah Jacobsen 

E: leah.jacobsen@psa.org.au or media@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Health Minister to address PSA national conference: The Home of Pharmacists

16 July

 

The Pharmaceutical Society of Australia (PSA) is pleased to announce that the Minister for Health, Disability, and Ageing, the Hon. Mark Butler MP, will join pharmacists from across Australia at PSA’s national conference, PSA26: the Home of Pharmacists.

 

The Hon. Mark Butler MP is set to deliver a ministerial address as part of the opening plenary on Friday 31 July.

 

PSA National President, Professor Mark Naunton MPS, said the presence of Minister Butler reflects the importance the Albanese government places on pharmacy policy and reform at a pivotal time for the profession.

 

“It is an exciting time for pharmacy, with PSA26 taking place as the profession is looking to broaden its contributions to improving access to care and supporting greater health outcomes for communities across Australia,” Professor Naunton said.

 

“PSA26 delegates will be able to hear first-hand from Minister Butler during the opening plenary, where he will provide key insights about the government’s priorities in healthcare and how pharmacists can assist with supporting these priorities.”

 

Assistant Minister for Rural and Regional Health, the Hon. Emma McBride MP FPS, and Shadow Minister for Health and Aged Care, Senator the Hon. Anne Ruston, will also address PSA26 on its opening day.

 

“We are equally excited to welcome Assistant Minister McBride and Shadow Minister Ruston to PSA26,” Professor Naunton continued.

 

“Our annual national conference continues to draw political leaders each year, which is a testament to the importance of pharmacists in Australia’s primary health system.”

 

PSA26 will be held from Friday 31 July to Sunday 2 August at the International Convention Centre in Sydney.

 

Registrations for PSA26 are still open. Those wishing to attend can register here.

 

 

 

Media contact: Leah Jacobsen

E: leah.jacobsen@psa.org.au or media@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of

Australia’s pharmacists across all practice settings. We want every Australian to have access to the

best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines

expertise at the forefront of our healthcare system.

Joanne Gross

Joanne is a consultant MMR credentialed pharmacist and Quality Use of Medicines Pharmacist at the Department of Health Tasmania. Her career has spanned rural and metropolitan hospital clinical pharmacy in four Australian states/territories, medical information and pharmacovigilance in the pharmaceutical industry in both the UK and Australia, pharmacy education, academic detailing, research and clinical governance. Joanne is honoured to represent the interests of Tasmanian pharmacists, consultant pharmacists, and the pharmacy profession through her roles on the PSA Tasmanian Branch Committee and Consultant Pharmacist CSI Leadership Committee and to now represent all PSA members and PSA as a PSA Board Director.